← Open Payments lookup

JOHN WENCESLAO: Open Payments

NPI 1740203868 · BLOOMFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,690 in 170 payments from 34 companies in 2025. Trend: 2023 $4,062 · 2024 $3,917 · 2025 $3,690

Food & beverage: $3,591Education: $100
CompanyPaymentsAmount
ABBVIE INC.27$448
AstraZeneca Pharmaceuticals LP16$421
GlaxoSmithKline, LLC.14$294
Esperion Therapeutics, Inc.10$193
Novartis Pharmaceuticals Corporation6$176
Ardelyx, Inc.8$171
Exact Sciences Corporation8$163
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$137
E.R. Squibb & Sons, L.L.C.7$137
Actelion Pharmaceuticals US, Inc.3$135

Products named: AIRSUPRA, TRELEGY ELLIPTA, NEXLETOL, IBSRELA, LEQVIO, UBRELVY, VRAYLAR, XIFAXAN.

Industry payments across CT — which companies pay providers there.